Cargando…

Evidence-based TDM for antiretroviral drugs

Detalles Bibliográficos
Autor principal:	Solas, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316019/ http://dx.doi.org/10.1186/1742-4690-7-S1-I11

Ejemplares similares

Diffusion of new antiretroviral drugs in CSF
por: Aweeka, Francesca
Publicado: (2010)

Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012)

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

Managing antiretrovirals in co-infected patients in 2012
por: Rockstroh, Jürgen
Publicado: (2012)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

Evidence-based guidelines for the management of diabetic foot problems
por: Shaw, Jonathan
Publicado: (2011)

Drug-drug interactions: it is not only CYP450's which matter
por: Back, David J
Publicado: (2010)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

Current evidence for the medical treatments of systemic juvenile idiopathic arthritis
por: Ruperto, Nicolino
Publicado: (2014)

Analgesic drug development: time to break the mould
por: Woolf, Clifford
Publicado: (2013)

Transporters used by parasites as drug targets: tempting but underexploited
por: Staines, Henry
Publicado: (2010)

Rehabilitation from symptomatic drugs overuse: yes, no, may be
por: Tassorelli, Cristina, et al.
Publicado: (2015)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

Tracing the history of South-American neotropical savannas and seasonally dry forests evidences from comparative phylogeography
por: Collevatti, Rosane, et al.
Publicado: (2011)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
por: Ward, Steve A, et al.
Publicado: (2010)

Molecular bases of neurophysiologic dysfunctions in migraine
por: Di Lorenzo, Cherubino
Publicado: (2015)

Genomics-based breeding in forest trees: are we there yet?
por: Neale, David
Publicado: (2011)

Synthetic and sequencing-based approaches to high-throughput genetic analysis
por: Shendue, Jay
Publicado: (2010)

Is there a role for cytokine-immune based therapy in HIV disease therapy?
por: Poli, Guido
Publicado: (2010)

Long-term results of implant-based functional rehabilitation of patients with ectodermal dysplasia
por: Reinert, Siegmar
Publicado: (2012)

Most of the 6.5% - 10% of human DNA bases that are functional now will soon be turned over
por: Ponting, Chris P, et al.
Publicado: (2010)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment
por: Gajewski, T
Publicado: (2014)

Therapeutic drug monitoring (TDM) of atazanavir in pregnancy
por: Else, LJ, et al.
Publicado: (2010)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

Biochemistry and genetics of folate metabolism
por: Rozen, Rima
Publicado: (2010)

Between a chicken and a grape: estimating the number of human genes
por: Pertea, Mihaela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_skd5fi6833ep92u6jn4e240p68